Related Experiment Video
Updated: Jun 14, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Tetracyclines: what a rheumatologist needs to know?
1Department of Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia. suzan_attar@hotmail.com
International Journal of Rheumatic Diseases
|April 9, 2010
Summary
Tetracyclines, broad-spectrum antibiotics, have evolved from acne treatment to exploring anti-inflammatory effects in rheumatic diseases. This review examines their rheumatological applications and therapeutic potential.
Area of Science:
- Pharmacology
- Rheumatology
- Microbiology
Background:
- Tetracyclines are broad-spectrum antibiotics discovered in the 1940s.
- Initially used for acne, their applications have expanded beyond antibacterial properties.
- Recent research highlights their anti-inflammatory, anti-angiogenic, and bone metabolism effects.
Purpose of the Study:
- To review the rheumatological applications of tetracyclines and their analogues.
- To explore the therapeutic potential of tetracyclines in treating rheumatic diseases.
Main Methods:
- Literature review of studies on tetracyclines in rheumatology.
- Analysis of research on the biological actions of tetracyclines beyond their antibiotic properties.
Main Results:
- Tetracyclines exhibit anti-inflammatory properties relevant to rheumatic conditions.
- Their effects on angiogenesis and bone metabolism are also being investigated for therapeutic use.
Conclusions:
- Tetracyclines and their analogues show promise for treating rheumatic diseases.
- Further research is warranted to fully elucidate their therapeutic mechanisms and efficacy in rheumatology.
Related Concept Videos
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...